Raquel Aguiar‐Ibáñez

Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer

Elizabeth Thurgar, Mark Gouldson, Suzette M. Matthijsse et al. · Journal of Medical Economics · 2021 · 36 citations · Full text

Medicine, Oncology, Pharmacoeconomics +16

Psychosocial interventions for non‐professional carers of people with Parkinson’s disease: a systematic scoping review

Susanne Hempel, Gill Norman, Su Golder et al. · Journal of Advanced Nursing · 2008 · 32 citations

Nursing, Health Sciences, Neurology +10

Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States

Raquel Aguiar‐Ibáñez, Chloë Hardern, Frank van Hees et al. · Journal of Medical Economics · 2022 · 32 citations · Full text

Medicine, Oncology, Pharmacoeconomics +15

Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States

Arielle G. Bensimon, Zheng‐Yi Zhou, Madeline Jenkins et al. · Journal of Medical Economics · 2019 · 30 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA

Arielle G. Bensimon, Zheng‐Yi Zhou, Madeline Jenkins et al. · Clinical Drug Investigation · 2020 · 22 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17